About Phage Lab
Phage Lab is a company based in Macul (Chile) founded in 2010 by Diego Belmar, Nicolas Ferreira, and Hans Pieringer. Phage Lab has raised $41 million across 2 funding rounds from investors including Collab Fund, Waterlemon Ventures and Kevin Efrusy. Phage Lab offers products and services including INSPEKTOR, FÓRMIDA, and PHAGEIN. Phage Lab operates in a competitive market with competitors including Zoetis, Ceva, Bio-Sourcing, Avecho and Aquilón Cyl, among others.
- Headquarter Macul, Chile
- Founders Diego Belmar, Nicolas Ferreira, Hans Pieringer
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Phagelab Chile Spa
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$41 M (USD)
in 2 rounds
-
Latest Funding Round
$11 M (USD), Series A
Jan 23, 2024
-
Investors
Collab Fund
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Phage Lab
Phage Lab offers a comprehensive portfolio of products and services, including INSPEKTOR, FÓRMIDA, and PHAGEIN.
Analyzes bacteria for virulence, resistance, and origins in industrial settings.
Applies bacteriophage combinations to control specific bacteria on farms.
Generates actionable data on bacteria using AI for farm interventions.
People of Phage Lab
Unlock access to complete
Funding Insights of Phage Lab
Phage Lab has successfully raised a total of $41M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $11 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Phage Lab
Phage Lab has secured backing from 6 investors, including venture fund and angel investors. Prominent investors backing the company include Collab Fund, Waterlemon Ventures and Kevin Efrusy.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm investing in multiple sectors
|
Locked | Locked | Locked | |
|
A venture capital fund focused on climate innovation startups.
|
Locked | Locked | Locked | |
|
Venture capital firm focused on empowering Latin American founders.
|
Locked | Locked | Locked |
Investor details for Phage Lab
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Phage Lab
Investment portfolio details for Phage Lab
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Phage Lab
Detailed financials for Phage Lab
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Phage Lab Comparisons
Peer comparison for Phage Lab
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Phage Lab
Phage Lab operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Zoetis, Ceva, Bio-Sourcing, Avecho and Aquilón Cyl, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Animal medicines, vaccines, and diagnostics are manufactured and supplied.
|
|
| Locked | Locked | Locked |
Animal health therapeutics are developed and supplied globally by Ceva.
|
|
| Locked | Locked | Locked |
Biopharmaceuticals for animals are manufactured and supplied through partnerships.
|
|
| Locked | Locked | Locked |
Developer of a drug delivery system for the safety of the animal and human health
|
|
| Locked | Locked | Locked |
Products enhancing animal productivity are developed and marketed.
|
Detailed competitors of Phage Lab
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Phage Lab
Complete news archive for Phage Lab
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Phage Lab
Phage Lab was founded in 2010 and raised its 1st funding round 12 years after it was founded.
Phage Lab is headquartered in Macul, Chile. It is registered at Macul, Region Metropolitana De Santiago, Chile.
Hans Pieringer is the current CEO of Phage Lab. They have also founded this company.
Phage Lab is a funded company, having raised a total of $41M across 2 funding rounds to date.
Founded in 2010 and based in Macul, Chile, bacteriophage technologies are utilized by the company to create therapeutic options against bacterial infections in animals. Collaborations are maintained with production entities in the poultry, pork, livestock, and aquaculture sectors to address infection challenges. Focus is placed on alternative treatments that support industry needs without relying on traditional antibiotics.
Phage Lab's top competitors include Zoetis, Ceva and Bio-Sourcing.
Phage Lab offers INSPEKTOR, FÓRMIDA, and PHAGEIN.
Phage Lab has 6 investors. Key investors include Collab Fund, Waterlemon Ventures, Kevin Efrusy, Nazca, and Kaszek.